Back
Nxera Pharma Co., Ltd. 10K Form
Sell
46
SOLTF
Nxera Pharma Co., Ltd.
Last Price:
$5.44
Seasonality Move:
4.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SOLTF News And Ratings
See the #1 stock for the next 7 days that we like better than SOLTF
SOLTF Financial Statistics
Sales & Book Value
| Annual Sales: | $198M |
|---|---|
| Cash Flow: | $-1M |
| Price / Cash Flow: | 57.47 |
| Annual Sales: | $4.30 |
| Price / Book: | 1.27 |
Profitability
| EPS (TTM): | -0.91810 |
|---|---|
| Net Income (TTM): | $-82.9M |
| Gross Margin: | $143.2M |
| Return on Equity: | -19.06% |
| Return on Assets: | -8.68% |
Nxera Pharma Co., Ltd. Earnings Forecast
Key Nxera Pharma Co., Ltd. Financial Ratios
-
The Gross Profit Margin over the past 23 years for SOLTF is 72.32%.
-
The Selling, General & Administrative Expenses for SOLTF have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 48.85% of Revenue.
-
The Net Earning history of SOLTF is -42.31% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 10 years.
Nxera Pharma Co., Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | SOLTF |
| Website: | nxera.life |
Debt
| Debt-to-Equity Ratio: | 0.94 |
|---|---|
| Current Ratio: | 2.54 |
| Quick Ratio: | 1.61 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SOLTF Technical Analysis vs Fundamental Analysis
Sell
46
Nxera Pharma Co., Ltd. (SOLTF)
is a Sell
Is Nxera Pharma Co., Ltd. a Buy or a Sell?
-
Nxera Pharma Co., Ltd. stock is rated a SellThe current Nxera Pharma Co., Ltd. [SOLTF] share price is $5.44. The Score for SOLTF is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.